Drugs Made In America Acquisition Corp. Ordinary Shares logo

Drugs Made In America Acquisition Corp. Ordinary Shares

DMAA | NASDAQ
Chart Builder DCF Calculator
$10.85
$0 (0.00%)
At close: Sep 22, 2026, 4:00 PM ET
$10.85
$0 (0.00%)
After-hours: Sep 22, 2026, 4:00 PM ET

Market Data

Market Cap
$263.4M
Enterprise Value
$264.33M
Beta
0.00
Average Volume
28.36K
Shares Outstanding (Diluted)
20.1M
Shares Change YoY
-40.04%
Institutional Ownership
99.43%
Exchange
NASDAQ
ISIN
KYG2847J1040

Price Performance

Price Change 1M
0.8%
Price Change 3M
2.0%
Price Change 6M
3.3%
Price Change YTD
4.5%
Price Change 1Y
5.3%
Price Change 3Y
8.8%
Price Change 5Y
8.8%
1M CAGR (ann.)
1.3%
1Y CAGR (ann.)
5.5%
5Y CAGR (ann.)
N/A
All-Time CAGR
5.6%

Valuation

PE Ratio
54.25
Forward PE
N/A
PEG Ratio
-0.55
Forward PEG
-0.55
PS Ratio
N/A
Forward PS
N/A
PB Ratio
1.91
P/FCF Ratio
-815.16
P/Adj. FCF Ratio
-815.16
P/OCF Ratio
-542.50
EV/Sales
N/A
EV/EBIT
-100.38
EV/EBITDA
-100.38
EV/FCF
-818.04
Earnings Yield
1.8%
FCF Yield
-0.1%
Adj. FCF Yield
-0.1%

Financial Health

Net Debt
$929.72K
Total Debt
$950K
Cash & Short-Term Investments
$20.28K
Total Assets
$146.9M
Current Ratio
0.02
Quick Ratio
0.02
Debt / Equity Ratio
0.01
Debt / EBITDA
-0.36
Debt / FCF
-2.94
OCF / Debt
-0.34
Interest Coverage
0.00
Altman Z-Score
17.14
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
0.0%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
N/A
Adj. FCF Margin
N/A
SBC / Revenue
0.0%
SBC Impact (per share)
N/A

Returns

Return on Assets
4.2%
Return on Equity
2.9%
Return on Invested Capital
-1.8%
Return on Capital Employed
-1.8%
Return on Tangible Assets
4.2%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
$5.56
Graham Upside
-48.8%
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
N/A
Price Target Upside
N/A

Cash Flow

Operating Cash Flow
$-323.13K
Free Cash Flow
$-323.13K
Adj. Free Cash Flow
$-323.13K
FCF Per Share
-$0.02
OCF Per Share
-$0.02
OCF/S Ratio
0.0%

Income Statement

Revenue
$0
Gross Profit
$0
Operating Income
$-2.63M
EBITDA
$-2.63M
Net Income
$6.09M
EPS (Diluted)
$0.20
Revenue / Employee
N/A
Profit / Employee
$3.05M
Employees
2

© 2026 bestshares.com. All rights reserved.